New study aims to sharpen predictions for liver transplant success
NCT ID NCT07383194
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study will analyze data from 3,000 living liver donors and their recipients to create a more accurate prediction model for early graft failure after living donor liver transplantation. Researchers will also test how well existing prediction models work. The goal is to give doctors a reliable tool to counsel patients and donors about risks before surgery.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could give doctors a more reliable tool to predict early graft failure after living donor liver transplantation, helping them counsel patients and donors better.
- What could go wrong
- This is an observational study analyzing existing data, not a treatment trial. The new model may not perform better than existing ones or may not apply to all patient groups.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for END STAGE LIVER DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Erasmus Medical Center
Rotterdam, South Holland, 3015 GD, Netherlands
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can immune cells predict herpesvirus danger in transplant patients?
- Muscle quality on MRI may foretell liver transplant success
- Better crystal ball for liver crisis: new scores put to the test
- A machine that keeps donor livers alive outside the body — could it transform transplantation?
- Frailty test could predict who survives liver transplant waiting list
- Could a single infusion of 'Trainer' cells free liver transplant patients from lifelong drugs?